|
1
|
Yin F, Liu X, Li D, Wang Q, Zhang W and Li
L: Tumor suppressor genes associated with drug resistance in
ovarian cancer (Review). Oncol Rep. 30:3–10. 2013.PubMed/NCBI
|
|
2
|
Sorbe B, Graflund M, Nygren L, Horvath G,
Swahn M, Boman K, Bangshöj R, Lood M and Malmström H: A phase II
study of docetaxel weekly in combination with carboplatin every
three weeks as first line chemotherapy in stage IIB-IV epithelial
ovarian cancer: Neurological toxicity and quality-of-life
evaluation. Int J Oncol. 40:773–781. 2012.
|
|
3
|
Pello OM, De Pizzol M, Mirolo M, Soucek L,
Zammataro L, Amabile A, Doni A, Nebuloni M, Swigart LB, Evan GI,
Mantovani A and Locati M: Role of c-MYC in alternative activation
of human macrophages and tumor-associated macrophage biology.
Blood. 119:411–421. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Okada M, Saio M, Kito Y, Ohe N, Yano H,
Yoshimura S, Iwama T and Takami T: Tumor-associated
macrophage/microglia infiltration in human gliomas is correlated
with MCP-3, but not MCP-1. Int J Oncol. 34:1621–1627.
2009.PubMed/NCBI
|
|
5
|
Zhang T, Ma Z, Wang R, Wang Y, Wang S,
Cheng Z, Xu H, Jin X, Li W and Wang X: Thrombin facilitates
invasion of ovarian cancer along peritoneum by inducing monocyte
differentiation toward tumor-associated macrophage-like cells.
Cancer Immunol Immunother. 59:1097–1108. 2010. View Article : Google Scholar
|
|
6
|
Wang X, Deavers M, Patenia R, Bassett RL
Jr, Mueller P, Ma Q, Wang E and Freedman RS: Monocyte/macrophage
and T-cell infiltrates in peritoneum of patients with ovarian
cancer or benign pelvic disease. J Transl Med. 4:302006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Webb S: A decade after the genome,
bioinformatics comes of age. Biotechniques. 51:157–161. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Keshava Prasad TS, Goel R, Kandasamy K,
Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R,
Shafreen B, Venugopal A, Balakrishnan L, Marimuthu A, Banerjee S,
Somanathan DS, Sebastian A, Rani S, Ray S, Harrys Kishore CJ, Kanth
S, Ahmed M, Kashyap MK, Mohmood R, Ramachandra YL, Krishna V,
Rahiman BA, Mohan S, Ranganathan P, Ramabadran S, Chaerkady R and
Pandey A: Human Protein Reference Database - 2009 update. Nucleic
Acids Res. 37(Database issue): D767–D772. 2009.PubMed/NCBI
|
|
9
|
Adamcsek B, Palla G, Farkas IJ, Derényi I
and Vicsek T: CFinder: locating cliques and overlapping modules in
biological networks. Bioinformatics. 22:1021–1023. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao Y, Lu XC, Yang HY, Liu XF, Cao J and
Fan L: The molecular mechanism of the anticancer effect of
atorvastatin: DNA microarray and bioinformatic analyses. Int J Mol
Med. 30:765–774. 2012.PubMed/NCBI
|
|
11
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: new features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bretz J, Garcia J, Huang X, Kang L, Zhang
Y, Toellner KM and Chen-Kiang S: Noxa mediates p18INK4c cell-cycle
control of homeostasis in B cells and plasma cell precursors.
Blood. 117:2179–2188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dickson MA, Tap WD, Keohan ML, D’Angelo
SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy
MM, Ustoyev Y, Crago AM, Singer S and Schwartz GK: Phase II trial
of the CDK4 inhibitor PD0332991 in patients with advanced
CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
J Clin Oncol. 31:2024–2028. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kolupaeva V and Basilico C: Overexpression
of cyclin E/CDK2 complexes overcomes FGF-induced cell cycle arrest
in the presence of hypophosphorylated Rb proteins. Cell Cycle.
11:2557–2566. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baydoun HH, Pancewicz J, Bai X and Nicot
C: HTLV-I p30 inhibits multiple S phase entry checkpoints,
decreases cyclin E-CDK2 interactions and delays cell cycle
progression. Mol Cancer. 9:3022010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lim S and Kaldis P: Cdks, cyclins and
CKIs: roles beyond cell cycle regulation. Development.
140:3079–3093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin WR, Lai MW and Yeh CT:
Cyclin-dependent kinase-associated protein phosphatase is
overexpressed in alcohol-related hepatocellular carcinoma and
influences xenograft tumor growth. Oncol Rep. 29:903–910. 2013.
|
|
18
|
Choi YH and Yoo YH: Taxol-induced growth
arrest and apoptosis is associated with the upregulation of the Cdk
inhibitor, p21WAF1/CIP1, in human breast cancer cells. Oncol Rep.
28:2163–2169. 2012.PubMed/NCBI
|
|
19
|
Nair BC, Vallabhaneni S, Tekmal RR and
Vadlamudi RK: Roscovitine confers tumor suppressive effect on
therapy-resistant breast tumor cells. Breast Cancer Res.
13:R802011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin JS, Hong SW, Lee SL, Kim TH, Park IC,
An SK, Lee WK, Lim JS, Kim KI, Yang Y, Lee SS, Jin DH and Lee MS:
Serum starvation induces G1 arrest through suppression of Skp2-CDK2
and CDK4 in SK-OV-3 cells. Int J Oncol. 32:435–439. 2008.PubMed/NCBI
|
|
21
|
Freedman RS, Ma Q, Wang E, Gallardo ST,
Gordon IO, Shin JW, Jin P, Stroncek D and Marincola FM: Migration
deficit in monocyte-macrophages in human ovarian cancer. Cancer
Immunol Immunother. 57:635–645. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yip P, Chen TH, Seshaiah P, Stephen LL,
Michael-Ballard KL, Mapes JP, Mansfield BC and Bertenshaw GP:
Comprehensive serum profiling for the discovery of epithelial
ovarian cancer biomarkers. PLoS One. 6:e295332011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Novitskiy SV, Ryzhov S, Zaynagetdinov R,
Goldstein AE, Huang Y, Tikhomirov OY, Blackburn MR, Biaggioni I,
Carbone DP, Feoktistov I and Dikov MM: Adenosine receptors in
regulation of dendritic cell differentiation and function. Blood.
112:1822–1831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar
|
|
26
|
Saccani A, Schioppa T, Porta C, Biswas SK,
Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A and Sica A:
p50 nuclear factor-κB overexpression in tumor-associated
macrophages inhibits M1 inflammatory responses and antitumor
resistance. Cancer Res. 66:11432–11440. 2006.
|
|
27
|
Curiel TJ, Coukos G, Zou L, Alvarez X,
Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L,
Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L,
Lackner A, Disis ML, Knutson KL, Chen L and Zou W: Specific
recruitment of regulatory T cells in ovarian carcinoma fosters
immune privilege and predicts reduced survival. Nat Med.
10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kryczek I, Zou L, Rodriguez P, Zhu G, Wei
S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A,
Alvarez X, Ochoa A, Chen L and Zou W: B7-H4 expression identifies a
novel suppressive macrophage population in human ovarian carcinoma.
J Exp Med. 203:871–881. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alon U: Biological networks: the tinkerer
as an engineer. Science. 301:1866–1867. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ravasz E and Barabási AL: Hierarchical
organization in complex networks. Phys Rev E Stat Nonlin Soft
Matter Phys. 67:0261122003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hartwell LH, Hopfield JJ, Leibler S and
Murray AW: From molecular to modular cell biology. Nature.
402:C47–C52. 1999. View
Article : Google Scholar : PubMed/NCBI
|
